Most Read Articles
29 Jun 2020
At the Novartis-sponsored VERIFY Soft Launch held at Le Meridien, Kuala Lumpur, two distinguished speakers spoke on the latest updates in glucose-lowering therapy and the benefit of early treatment intensification using combination therapy (ie, vildagliptin/metformin) in the management of T2DM.

Predictors of new-onset diabetes mellitus after kidney transplant

03 Jul 2020
Hospital Authority is set to introduce a pair exchange scheme for kidney transplants by the second half of 2018.

New-onset diabetes mellitus is relatively common after kidney transplantation, a new meta-analysis has found. Risk factors include older age, body mass index (BMI), family history, and some comorbidities.

Accessing the databases of PubMed, Web of Science, Embase, and the Cochrane library, researchers were able to retrieve 24 case-control studies eligible for inclusion into the meta-analysis. This corresponded to 6,127 kidney transplant patients, of whom 1,598 developed new-onset diabetes mellitus after the procedure.

Pooled analysis of 17 studies showed that, after the heterogeneity test (p<0.00001), age was a significant risk factor for the development of new-onset diabetes mellitus after kidney transplant (mean difference [MD], 6.05, 95 percent confidence interval [CI], 4.33–7.78; p<0.00001). Sex, on the other hand, was not a significant correlate of the outcome (odds ratio [OR], 1.00, 95 percent CI, 0.88–1.13; p=0.97).

Other significant risk factors included polycystic kidney disease (OR, 1.69, 95 percent CI, 1.22–2.34; p=0.002), a family history of diabetes mellitus (OR, 3.14, 95 percent CI, 1.87–5.27; p<0.0001), high BMI (MD, 1.82, 95 percent CI, 1.35–2.30; p<0.00001), and acute rejection (OR, 1.97, 95 percent CI, 1.61–2.41; p<0.00001).

Similarly, the use of tacrolimus (OR, 1.20, 95 percent CI, 1.02–1.41; p=0.03) emerged as a significant risk factor, while other medications, such as sirolimus, cyclosporin A, and steroids, were not. Infections with hepatitis B (OR, 3.53, 95 percent CI, 1.12–11.13; p=0.03) and C (OR, 1.51, 95 percent CI, 1.01–2.24; p=0.04) were also significant correlated of new-onset diabetes mellitus.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
29 Jun 2020
At the Novartis-sponsored VERIFY Soft Launch held at Le Meridien, Kuala Lumpur, two distinguished speakers spoke on the latest updates in glucose-lowering therapy and the benefit of early treatment intensification using combination therapy (ie, vildagliptin/metformin) in the management of T2DM.